(19)
(11)EP 3 013 843 A1

(12)

(43)Date of publication:
04.05.2016 Bulletin 2016/18

(21)Application number: 14817999.7

(22)Date of filing:  24.06.2014
(51)International Patent Classification (IPC): 
C07H 19/06(2006.01)
C07H 19/11(2006.01)
C07H 19/20(2006.01)
A61K 31/7072(2006.01)
A61K 31/708(2006.01)
C07H 19/10(2006.01)
C07H 19/16(2006.01)
A61K 31/7068(2006.01)
A61K 31/7076(2006.01)
A61P 31/14(2006.01)
(86)International application number:
PCT/US2014/043841
(87)International publication number:
WO 2014/209983 (31.12.2014 Gazette  2014/53)
(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30)Priority: 26.06.2013 US 201361839756 P

(71)Applicant: Alios Biopharma, Inc.
South San Francisco, CA 94080 (US)

(72)Inventors:
  • DYATKINA, Natalia
    Mountain View, CA 94040 (US)
  • WANG, Guangyi
    Carlsbad, CA 92008 (US)
  • BEIGELMAN, Leonid
    San Mateo, CA 94402 (US)
  • RAJWANSHI, Vivek, Kumar
    Cupertino, CA 95014 (US)

(74)Representative: Zacco Sweden AB 
P.O. Box 5581
114 85 Stockholm
114 85 Stockholm (SE)

  


(54)SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF